Clinical impact of a
Journal
JAC-antimicrobial resistance
ISSN: 2632-1823
Titre abrégé: JAC Antimicrob Resist
Pays: England
ID NLM: 101765283
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
30
07
2019
revised:
23
01
2020
accepted:
06
04
2020
entrez:
5
7
2021
pubmed:
6
7
2021
medline:
6
7
2021
Statut:
epublish
Résumé
To evaluate the clinical impact of a bedside visit to patients with a positive All patients ≥18 years old with positive CDI laboratory tests hospitalized between January 2017 and August 2017 received an immediate bedside intervention that consisted mainly of checking protective measures and providing recommendations on infection control and the management of CDI and other infections. A total of 214 patients were evaluated. The infectious disease (ID) physician was the first to establish protective measures in 25.2% of the cases. In 22/29 (75.9%) cases, physicians in charge accepted ID consultant recommendations to stop CDI treatment in asymptomatic patients. Unnecessary non-CDI antibiotics were discontinued in 19.1% of the cases. ID recommendations were not accepted by physicians in charge in only 12.6% of the cases. A bedside rapid intervention for patients with a CDI-positive faecal sample was effective in avoiding overdiagnosis and unnecessary antibiotic treatment, optimizing anti-CDI drugs, increasing compliance with infection control measures and providing educational advice.
Identifiants
pubmed: 34223003
doi: 10.1093/jacamr/dlaa037
pii: dlaa037
pmc: PMC8210181
doi:
Types de publication
Journal Article
Langues
eng
Pagination
dlaa037Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
Références
Lancet Infect Dis. 2017 Sep;17(9):990-1001
pubmed: 28629876
Infect Dis Clin North Am. 2015 Mar;29(1):123-34
pubmed: 25677706
J Clin Pathol. 2011 Jan;64(1):1-5
pubmed: 21118850
Am J Infect Control. 2016 Dec 1;44(12):1539-1543
pubmed: 27592160
Anaerobe. 2016 Feb;37:38-42
pubmed: 26505927
Clin Microbiol Infect. 2018 Jul;24(7):682-683
pubmed: 29505883
N Engl J Med. 2015 Apr 16;372(16):1539-48
pubmed: 25875259
Lancet Infect Dis. 2013 Nov;13(11):936-45
pubmed: 24007915
Clin Microbiol Infect. 2009 Dec;15(12):1053-66
pubmed: 19929972
Infect Control Hosp Epidemiol. 2020 Jan;41(1):44-51
pubmed: 31708000
Infect Control Hosp Epidemiol. 2017 Jan;38(1):127-129
pubmed: 27766987
Curr Opin Gastroenterol. 2019 Jan;35(1):20-24
pubmed: 30394898
Infect Drug Resist. 2014 Mar 17;7:63-72
pubmed: 24669194
BMC Infect Dis. 2016 Jun 18;16:303
pubmed: 27316794
JAMA. 2015 Jan 27;313(4):398-408
pubmed: 25626036
Infect Control Hosp Epidemiol. 2013 Nov;34(11):1222-4
pubmed: 24113611
Am J Infect Control. 2019 Apr;47(4):400-405.e1
pubmed: 30554878
J Hosp Infect. 2018 Aug;99(4):436-442
pubmed: 29410012
Surg Clin North Am. 2014 Dec;94(6):1335-49
pubmed: 25440127
J Dig Dis. 2019 Sep;20(9):460-466
pubmed: 31278840
Adv Exp Med Biol. 2018;1050:1-12
pubmed: 29383660
Clin Microbiol Infect. 2018 May;24(5):463-468
pubmed: 29269092
Expert Rev Anti Infect Ther. 2017 Nov;15(11):1027-1040
pubmed: 28980505
Lancet Infect Dis. 2008 Dec;8(12):777-84
pubmed: 18977696
Med Glas (Zenica). 2018 Aug 1;15(2):122-131
pubmed: 30047540
JAMA Surg. 2016 Apr;151(4):314-22
pubmed: 26606675
J Gastroenterol Hepatol. 2016 Dec;31(12):1927-1932
pubmed: 27043242
Infect Control Hosp Epidemiol. 2016 Sep;37(9):1068-78
pubmed: 27322606
J Antimicrob Chemother. 2007 May;59(5):990-5
pubmed: 17387117
PLoS One. 2017 Mar 3;12(3):e0172410
pubmed: 28257438
Infect Control Hosp Epidemiol. 2015 Jun;36(6):681-7
pubmed: 25783204
Infect Control Hosp Epidemiol. 2011 Apr;32(4):387-90
pubmed: 21460491
Eur J Clin Microbiol Infect Dis. 2016 Dec;35(12):1949-1956
pubmed: 27590621
Am J Surg. 2017 Mar;213(3):565-571
pubmed: 28131326
Pharmacotherapy. 2012 Aug;32(8):744-54
pubmed: 23307522
J Infect. 2015 Mar;70(3):264-72
pubmed: 25452039
Clin Microbiol Infect. 2012 Dec;18 Suppl 6:5-12
pubmed: 23121549
Clin Infect Dis. 2018 Mar 19;66(7):987-994
pubmed: 29562266
Am J Infect Control. 2019 Mar;47(3):340-342
pubmed: 30420098
Am J Infect Control. 2018 Apr;46(4):456-458
pubmed: 29305285
Clin Microbiol Infect. 2009 Dec;15(12):1067-79
pubmed: 19929973
Infect Control Hosp Epidemiol. 2019 Jan;40(1):65-71
pubmed: 30409240
Am J Infect Control. 2016 Dec 1;44(12):1684-1686
pubmed: 27908435
J Hosp Infect. 2010 Aug;75(4):325-6; author reply 326-7
pubmed: 20444522
J Antimicrob Chemother. 2018 Feb 1;73(2):517-526
pubmed: 29177477
Med Mal Infect. 2018 Feb;48(1):23-29
pubmed: 29336929
Infect Dis Clin North Am. 2020 Mar;34(1):51-65
pubmed: 31836331
J Infect Prev. 2018 Jul;19(4):191-194
pubmed: 30013624
Open Forum Infect Dis. 2018 Sep 10;5(10):ofy226
pubmed: 30302353
Infect Dis Clin North Am. 2015 Mar;29(1):63-82
pubmed: 25595842
Open Microbiol J. 2017 Dec 29;11:360-371
pubmed: 29399217
Infect Control Hosp Epidemiol. 2014 Oct;35 Suppl 3:S86-95
pubmed: 25222903